Dragon Vascular, Inc.

Dragon Vascular, Inc. , founded in 2024, is a pioneering company specializing in vascular medical devices that improve patient outcomes in the treatment of vascular conditions. Dragon Vascular, Inc. focuses on developing innovative solutions for vascular treatment in Fremont, US.

Founded in 2024, the company successfully raised USD 18. 89 mn in its latest funding round in October 2025, totaling USD 18. 89 mn raised to date. The firm has completed one deal and operates independently without any known subsidiaries or parent companies.

Dragon Vascular specializes in innovative vascular medical devices designed to enhance patient outcomes in the treatment of various vascular conditions. Their core product offerings include advanced stent systems and catheter technologies that are engineered to improve the precision and safety of vascular interventions. These products are utilized primarily in minimally invasive procedures aimed at addressing issues such as arterial blockages and peripheral vascular diseases. Targeted towards hospitals and outpatient surgical centers, Dragon Vascular serves a diverse client base that includes cardiovascular specialists and vascular surgeons across North America and Europe.

The company’s emphasis on continuous improvement and cutting-edge technology ensures that their products remain at the forefront of the medical device industry, catering to the evolving needs of healthcare providers and their patients. Dragon Vascular generates revenue through direct sales of its medical device products to healthcare facilities and professionals. Transactions typically involve direct contracts with hospitals and surgical centers, where bulk orders of their flagship stent systems and catheter technologies are placed. The company may engage in a B2B sales model, allowing for long-term partnerships and agreements with medical institutions to supply their devices on an ongoing basis.

Pricing structures for these products are tailored to institutional budgets and may include volume discounts or contract-specific pricing arrangements. As a result, Dragon Vascular's revenue is driven by consistent demand from healthcare providers seeking reliable solutions for vascular treatment. In October 2025, Dragon Vascular, Inc. plans to utilize the USD 18.

89 mn raised in its latest funding round to develop new products aimed at enhancing their current offerings in vascular treatment. The company is targeting expansions into new markets in Europe and North America by late 2026, ensuring broader availability of their advanced medical devices. This strategic growth approach aims to strengthen partnerships with healthcare providers and improve access to their innovative vascular solutions.